Description
Recombinant monoclonal antibody to Ly6G. Manufactured using AbAbтАЩs Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 1A8. This is a murinised antibody to reduce immunogenicity in vivo and was created using our proprietary Fc SilentтДв engineered Fc domain, containing key point mutations that abrogate binding of Fc Receptor and complement.
Target
Ly6G
Target Alias Names
LGR-1, y-6G, GR1, Lymphocyte antigen 6G
Isotype/Mimetic
IgG2a
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression